Doravirine

PIFELTRO

Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor

NADAC/unit $60.9498

No Shortage Tier 1: 17.9%

vs. brand PIFELTRO: Generic saves up to -509% per unit

Covered Lives

Generic Manufacturers

MERCK SHARP AND DOHME CORP A SUB OF MERCK AND CO INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Doravirine drfinder.aiFind doctors who prescribe Doravirine rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Doravirine

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.